A Patient‐Derived 3D Cyst Model of Polycystic Kidney Disease That Mimics Disease Development and Responds to Repurposing Candidates
Clinical and Translational Science · 2025
DOI: 10.1111/cts.70214 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Science, 2025. Verfasst von Alina Hartwig und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Drug Repositioning, Polycystic Kidney, Autosomal Dominant, Cysts. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease. Its progressively expanding, fluid‐filled renal cysts eventually lead to end‐stage renal disease. Despite the relatively high prevalence, treatment options are currently limited to a single drug approved by the FDA and EMA. Here, we investigated human ADPKD patient‐derived three‐dimensional cyst cultures (3DCC) as an in vitro model for ADPKD and drug repurposing research. First, we analyzed the proteomes of 3DCC derived from healthy and diseased tissues. We then compared the protein expression profiles with those of reference tissues, mainly from the same patients. We quantified 290 proteins affecting drug disposition and proposed target proteins for drug treatment. Lastly, we investigated the functional response of the quantified target proteins after exposure to repurposing candidates in the 3DCC. Proteomic profiling of human 3DCC reflected previously reported pathophysiological alterations, including aberrant protein expression in inflammation and metabolic reprogramming. While the 3DCCs largely recapitulated the disease phenotype in vitro, drug transporter expression was reduced compared to in vivo conditions. Target proteins for proposed repurposing candidates showed similar expression in vitro and in tissues. Exposure to these repurposing candidates inhibited cyst swelling in vitro, supporting the suitability of the 3DCC for ADPKD drug screening. In summary, our results provide new insights into the ADPKD proteome and offer a starting point for further research to improve treatment options for affected individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Uppsala University, Uppsala, Sweden.
- In Silico Discovery, J&J Innovative Medicine, Beerse, Belgium.
- Division of Medicinal Chemistry, Leiden Academic Centre for Drug Research, Leiden, the Netherlands.
- Crown Bioscience Netherlands B.V, Leiden, the Netherlands.
- Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
ORCID-Profile: Alina Hartwig, Bola Khalil, Margarita Iljin, Leo S Price, Natalia Dyubankova, Gerard J P van Westen, Herman van Vlijmen, Dorien J M Peters, Per Artursson
Zitieren
APA
Hartwig, A., Khalil, B., Iljin, M., Bange, H., Price, L. S., Dyubankova, N., van Westen, G. J. P., van Vlijmen, H., Peters, D. J. M., & Artursson, P. (2025). A Patient‐Derived 3D Cyst Model of Polycystic Kidney Disease That Mimics Disease Development and Responds to Repurposing Candidates. Clinical and Translational Science. https://doi.org/10.1111/cts.70214
Vancouver
Hartwig A, Khalil B, Iljin M, Bange H, Price LS, Dyubankova N, et al. A Patient‐Derived 3D Cyst Model of Polycystic Kidney Disease That Mimics Disease Development and Responds to Repurposing Candidates. Clinical and Translational Science. 2025. doi:10.1111/cts.70214
BibTeX
@article{Hartwig2025,
author = {Hartwig, Alina and Khalil, Bola and Iljin, Margarita and Bange, Hester and Price, Leo S and Dyubankova, Natalia and van Westen, Gerard J P and van Vlijmen, Herman and Peters, Dorien J M and Artursson, Per},
title = {A Patient‐Derived 3D Cyst Model of Polycystic Kidney Disease That Mimics Disease Development and Responds to Repurposing Candidates},
journal = {Clinical and Translational Science},
year = {2025},
doi = {10.1111/cts.70214}
}
EUVIMED